TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07038408: Multi-center, Open-label, Prospective, Randomized Study to Show Long-term Efficacy of DCB Treatment With Bail-out BRS in Comparison to BRS Treatment of De-novo Native Coronary Artery Lesions in a Relatively Young PCI Pop

Sponsor: Ceric Sàrl · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 2256 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07038408 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07038408 Rescue Dossier →